VC  OVP Venture Partners

http://www.ovp.com





     Office Locations:

One SW Columbia, Suite 1675
Portland, OR 97258
Phone: 503-697-8766
Fax: 503-697-8863

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Communications & Networking
  • Defense & Homeland Security
  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Semiconductor
  • Software & Internet

  •  

    Description:

    Established in 1983, OVP Venture Partners invests capital in new companies in growing markets-digital biology, clean tech and information technology. OVP's initial investment is typically about $1 million to $5 million, usually in partnership with other venture capital firms, and grows to $8 million to $15 million over the life of the deal. The firm's three investing partners manage over $750 million. Out of more than 103 investments over 25 years, OVP has produced 23 IPOs and 32 acquisitions. OVP focuses on companies located in the Pacific Northwest.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Bill Funcannon Managing Director and Chief Financial Officer
    Chad Waite Managing Director
    Gerry Langeler Managing Director
    Linda Hoban Director of Marketing and Investor Communications

     

    Portfolio companies include:


      Accelerator III
        web link


      Acylin Therapeutics
        web link


      Adapx
        web link


      Aggregate Knowledge
        web link


      Allozyne
        web link


      Collaborative Software
        web link


      Complete Genomics
        web link


      CradlePoint Technology
        web link


      DataSphere
        web link


      Datasphere Technologies
        web link


      EnerG2
        web link


      GainSpan
        web link


      GenoLogics
        web link


      Groove BioPharma
        web link


      LeMond Fitness
        web link


      Limerick BioPharma
        web link


      Logic Modeling
        web link


      M2EPower
        web link


      Max-Viz
        web link


      NanoString Technologies
        web link


      Novomer
        web link


      OncoFactor
        web link


      Precision Demand
        web link


      RedSeal
        web link


      Scout Analytics
        web link


      Serus
        web link


      Symform
        web link


      Talyst
        web link


      Tigo Energy
        web link


      Triconex
        web link


      TZero
        web link


      Vantos
        web link


      Verdezyne
        web link


      Viral Logic Systems Technology
        web link


      Watchguard Technologies
        web link


      Xilinx
        web link


     

    Recent News: